Results 81 to 90 of about 27,419 (207)

Science of Biosimilars

open access: yes, 2017
Biosimilar therapeutic proteins in oncology offer the potential to decrease costs while providing safety and efficacy profiles consistent with their respective reference or originator products.
R. Donald Harvey
core   +1 more source

National Pharmacovigilance Assessment of Oral Adverse Events Following COVID-19 Vaccination in Germany (2020-2023)

open access: yesInternational Dental Journal
Objectives: Pharmacovigilance efforts for COVID-19 vaccines have largely focused on severe adverse events (AEs), while nonserious, yet distressing, AEs, such as oral AEs, remain underexamined. This study aimed to analyse oral AE reporting patterns in the
Abanoub Riad
doaj   +1 more source

Causal inference for evaluating prescription opioid abuse using trend‐in‐trend design

open access: yes, 2019
PURPOSE: One response to the opioid crisis in the United States has been the development of opioid analgesics with properties intended to reduce non-oral use.
Dart, Richard C.   +4 more
core   +1 more source

Safety profile of oxcarbazepine: results from a prescription-event monitoring study [PDF]

open access: yes, 2010
Purpose: To monitor safety of oxcarbazepine, prescribed in primary care in England, using prescription-event monitoring (PEM). Methods: Postmarketing surveillance using observational cohort technique of PEM.
Layton, D.   +3 more
core   +1 more source

Safety profile assessment of HPV4 and HPV9 vaccines through the passive surveillance system of the Veneto Region (Italy) between 2008 and 2022: A 15-year retrospective observational study

open access: yesVaccine: X
In Veneto Region, HPV vaccine has been actively offered to 12 year-old females since 2008, and to 12 year-old males since 2015. The study aims to analyze the safety profile of HPV4v and HPV9v vaccines and perform a case-by-case review of conditions of ...
Diana Dalla Valle   +13 more
doaj   +1 more source

MANAGING THE RISKS FROM MEDICAL PRODUCT USE

open access: yes, 2007
This report is the result of that review. Briefly, the Task Force assessed risk management practices within the overall healthcare delivery system, focusing on the roles and responsibilities of each participant.
Tab Le Of   +2 more
core  

HEALTH VALUE IN FOOD SAFETY SURVEILLANCE INITIATIVES

open access: yes
Recognizing the increasing concern about the potential health effects of genetically modified foods, this research provides a framework for economic value of monitoring genetically modified food for their potential long-term human health effects. This is
Amanor-Boadu, Vincent   +2 more
core  

The FDA and the Tort System: Postmarketing Surveillance, Compensation, and the Role of Litigation

open access: yes, 2013
Both the tort system and the FDA seek to protect consumers of medical products. The tort system provides compensation when a consumer is harmed by a defective product and sets incentives for companies to design safer products.
Struve, Catherine T
core  

Safety and tolerability of ribosome-component immune modulator in adults and children

open access: yes, 2009
Ribosomal preparations (ribosome-component immune modulators [RCIMs]) do not contain attenuated bacteria and, in contrast to live bacterial extracts, which may induce severe side effects, retain immune stimulating activity without infectious capability ...
S. Veehof   +4 more
core   +1 more source

Reviews on pharmacoeconomic drug surveillance

open access: yes, 2014
The study aimed to identify pharmacoeconomic studies in pharmacovigilance and to observe the economic outcomes in post-marketing surveillance. Therefore, a bibliographic survey was performed in databases Lilacs, PubMed/ Bireme.
Abjaude, Samir Antonio Rodrigues [UNESP]   +2 more
core  

Home - About - Disclaimer - Privacy